Eastern Biotech & Life Sciences organizes 'Advanced Genetic Testing in the prediction & diagnosis of disease' conference

Genetic Testing has now reached a stage where it is becoming increasingly applicable for rapid and accurate diagnosis of common infective / congenital disorders as well as the basis for prediction of cancers and lifestyle diseases.

These advances are opening up new avenues for the clinicians to offer their patients innovative tools to achieve optimum health. 'Advanced Genetic Testing in the prediction & diagnosis of disease' conference is aiming to introduce a broad spectrum of new diagnostic tools available to clinicians in an attempt to incorporate there use in routine practices.

The conference is proudly organized by Eastern Biotech & Life Sciences; a Genetic Biotechnological company based out of DuBiotech, Dubai and will be held in Dubai (UAE) on the 27th of November 2008. It is supported by the Ministry of Health, United Arab Emirates and has been formally granted 3.0 CME credit points.

The conference aims to promote knowledge exchange on using diagnostic testing as a tool for supporting the advancement of genetic innovation throughout the world. The conference will bring together approximately 75 key industry figureheads and stakeholders throughout the GCC headlined by 4 internationally acclaimed genetic specialists presenting their knowledge and ideas fostering genetic and biotechnological innovation specifically:
- Genetic Disorders in Arab Populations
- Syndrome Based Diagnostics: A Single Test using DNA Macrochip to Detect Multiple Pathogens in Eye and Brain
- Birth Defects and Congenital Abnormalities in UAE: Risk Reduction by Counseling and Genetic Testing Using Molecular and Cytogenetic Techniques
- New DNA Based Diagnostic Tests for Prediction of Diabetes, Heart Disease, Breast and Prostate Cancer

As a part of the event Eastern Biotech & Life Sciences will conduct its inaugural network meeting including product development and contribution program aiming to enhance the education and management of genetic diagnostic testing tools within the GCC.